PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Perit Dial Int 19(2): 160-164 1999
© 1999 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Odama, U.
Right arrow Articles by Korbet, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Odama, U.
Right arrow Articles by Korbet, S.
Peritoneal Dialysis International, Vol 19, Issue 2, 160-164
Copyright © 1999 by International Society for Peritoneal Dialysis

Case Reports

Sclerosing peritonitis and systemic lupus erythematosus: a report of two cases

UO Odama, DJ Shih, and SM Korbet

Department of Internal Medicine, Rush-Presbyterian-St. Lukes Medical Center, Chicago, Illinois 60612, USA.

OBJECTIVE: To heighten the awareness of a possible association of sclerosing peritonitis in patients with systemic lupus erythematosus (SLE). METHODS AND RESULTS: Over the course of 17 years (from January 1981 to December 1997), 371 patients were treated with continuous ambulatory peritoneal dialysis (CAPD) at Rush-Presbyterian-St Lukes Medical Center. The patients were followed on CAPD for an average of 25 +/- 21 (SD) months with a median of 19 months (range 0.2-115 months). During this time only 2 (0.5%) patients were diagnosed with sclerosing peritonitis, and both had SLE with ongoing evidence of active disease while on CAPD. With a total of 26 SLE patients being treated with CAPD during the observation period, the prevalence of sclerosing peritonitis can be said to be as high as 8% in this patient population. CONCLUSION: These cases suggest that autoimmune diseases, such as SLE, that are well known to cause immune-mediated serositis may represent an additional factor predisposing to the development of sclerosing peritonitis in patients treated with CAPD.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
A. Rietveld and J. H. M. Berden
Renal replacement therapy in lupus nephritis
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3056 - 3060.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 1999 by Multimed Inc.